Rosalind Advisors, Inc. is involved in life science investing and biotech funds.

Rosalind Advisors, Inc.

Rosalind Advisors, Inc. | 132 followers on LinkedIn. Rosalind Advisors, Inc. is a biotech investment manager. Our biotech funds’ strategy is market agnostic, operating at the intersection of science and finance with the goal of capitalizing on consistent market inefficiencies and arbitrage opportunities. Since its founding in 2006, the fund has had a consistent track-record of uncorrelated abnormal returns.

Associate Portfolio Manager - Life Sciences

Ritchie Truong, CFA

President at Rosalind Advisors Inc.

Steven Salamon

Analyst

Daniel Moshe

Passionate to help people to achieve their financial goals by creating financial plans and strategies specific to their situation, risk profile and…

Thilaksi Chandrasekar

Domain Not Resolving

HSTS

Amazon

Font Awesome

Cloudflare CDN

Google

Google Cloud

YouTube

Google Conversion Linker

reCAPTCHA v3

Co-Founder, President and CEO

Gil Aharon

Co-Founder

PolyPid offers a technology platform that enables a controlled and prolonged release of any active pharmaceutical ingredients (API).

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

Protalix is a biopharmaceutical company that is revolutionizing the development and manufacturing of recombinant therapeutic proteins.

InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.

Lev Pharmaceuticals is focused on developing therapeutic products for the treatment of inflammatory diseases.

Investors Active in Israel

Toronto Investors

Post IPO Investors with Investments in Europe, Middle East, and Africa (EMEA)

Venture Capital Investors with Investments in Tel Aviv

Rosalind Capital Partners is an Ontario based venture capital fund that invests in the life sciences sector.

Toronto

Ontario

Canada

North America

Rosalind Capital Partners

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 17, 2024 4:09 PM	ea89fbaa
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 17, 2024 4:09 PM	cd6e4595
crunchbase trigger	general	Nov 17, 2024 4:09 PM	9e3e0137
crunchbase profile	general	Nov 17, 2024 4:17 PM	a89954ad
li profile	general	Nov 17, 2024 4:09 PM	8c3ff122
translate crunchbase fundingrounds	general	Nov 17, 2024 4:38 PM	b66e8528
peers	general	Nov 17, 2024 4:09 PM	83761d6f
news basic	general	Nov 17, 2024 4:09 PM	d58db7ec
bundesanzeiger	filings
financials download nd	financials
private financials	financials

ROSA

COM:ROSALINDCAP

Rosalind Advisors, Inc.